Prevalence and distribution of human papillomavirus findings in swab specimens from gynaecology clinics of the east coast of Spain

References

• Parkin D M, Bray F. In: Chapter 2: the burden of HPV-related cancers. Vaccine 2006;24(Suppl 3):S11–S25.
   Google Scholar
• Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev Cancer 2002;2: 342–50.
   PubMed Web of Science ®Google Scholar
• Roden R, Wu TC. How will HPV vaccines affect cervical cancer? Nature Rev Cancer 2006;6:753–63.
   PubMed Web of Science ®Google Scholar
• Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 2006;110:525–41.
   PubMed Web of Science ®Google Scholar
• De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324:17–27.
   PubMed Web of Science ®Google Scholar
• Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, . Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518–27.
   PubMed Web of Science ®Google Scholar
• Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, . Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12–9.
   PubMed Web of Science ®Google Scholar
• Bosch FX, de Sanjose S. In: Chapter 1: human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003;31:3–13.
   PubMedGoogle Scholar
• De Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz N, . Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 2003;10:788–93.
   Google Scholar
• De Sanjosé S, Alemany L, Castellsagué X, Bosch FX. Human papillomavirus vaccines and vaccine implementation. Womens Health (Lond Engl) 2008;4:595–604.
   PubMedGoogle Scholar
• Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, . Proof of Principle Study Investigators. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347:1645–51.
   PubMed Web of Science ®Google Scholar
• Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, . Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271–8.
   PubMed Web of Science ®Google Scholar
• The European Medicines Agency. EPARs for authorised medicinal products for human use. Gardasil: European Public Assessment Report. Available at: http://www.emea.europa.eu/humandocs/Humans/EPAR/gardasil/gardasilM2.htm (accessed October 23, 2009).
   Google Scholar
• El Consejo Interterritorial aprueba la inclusión de la vacuna del virus del papiloma humano en el calendario vacunal del SNS por unanimidad. Ministry of Health, Government of Spain. Press release: [14]. http://www.msc.es/gabinete Prensa/notaPrensa/desarrolloNotaPrensa.jsp?id=992 (accessed January 23, 2010).
   Google Scholar
• Martorell M, Gil-Salom M, Pérez-Vallés A, Garcia JA, Rausell N, Senpere A. Presence of human papillomavirus DNA in testicular biopsies from non obstructive azoospermic men. Arch Pathol Lab Med 2005;129:1132–6.
   PubMedGoogle Scholar
• Szuhai K, Sandhaus E, Kolkman-Uljee SM, Lemaître M, Truffert JC, Dirks RW, . A novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon polymerase chain reaction. Am J Pathol 2001;159:1651–60.
   PubMed Web of Science ®Google Scholar
• National Center for Biotechnology Information. Basic Local Alignment Search Tool. Available at: http://www.ncbi.nlm.nih.gov/BLAST (accessed January 23, 2010).
   Google Scholar
• Feoli-Fonseca JC, Oligny LL, Yotov WV. New method for automatic identification and typing of single and multiple superimposed human papillomavirus sequences. Diagn Mol Pathol 1999;8:216–21.
   PubMedGoogle Scholar
• Spanish Statistical Institute, Government of Spain. Census 2007. Available at: http://www.ine.es (accessed January 23, 2010).
   Google Scholar
• Ortiz M, Torres M, Muñoz L, Fernández-García E, Canals J, Cabornero AI, . Oncogenic human papillomavirus (HPV) type distribution and HPV type 16 E6 variants in two Spanish population groups with different levels of HPV infection risk. J Clin Microbiol 2006;44:1428–34.
   PubMedGoogle Scholar
• Agorastos T, Dinas K, Lloveras B, Bosch FX, Kornegay JR, Bontis JN, . Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece. Eur J Cancer Prev 2004;13:145–7.
   PubMedGoogle Scholar
• Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T. . Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008;123: 1864–70.
   PubMed Web of Science ®Google Scholar
• Ronco G, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, . Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 2005;41:297–305.
   PubMed Web of Science ®Google Scholar
• Boulanger JC, Sevestre H, Bauville E, Ghighi C, Harlicot JP, Gondry J. Epidemiology of HPV infection. Gynecol Obstet Fertil 2004;32:218–23.
   PubMedGoogle Scholar
• De Vuyst H, Clifford G, Li N, Franceschi S. HPV infection in Europe. Eur J Cancer 2009;45:2632–9.
   PubMed Web of Science ®Google Scholar
• Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, . Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003; 103:413–21.
   PubMed Web of Science ®Google Scholar
• Sukvirach S, Smith JS, Tunsakul S, Muñoz N, Kesararat V, Opasatian O, . Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003;187:1246–56.
   PubMed Web of Science ®Google Scholar
• Pham TH, Nguyen TH, Herrero R, Vaccarella S, Smith JS, Nguyen Thuy TT, . Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003;104:213–20.
   PubMed Web of Science ®Google Scholar
• Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJ, . Human papillomavirus infection in Shanxi Province, People’s Republic of China: a population-based study. Br J Cancer 2006;95:96–101.
   PubMed Web of Science ®Google Scholar
• Franceschi S, Rajkumar R, Snijders PJ, Arslan A, Mahé C, Plummer M, . Papillomavirus infection in rural women in southern India. Br J Cancer 2005;92:601–6.
   PubMed Web of Science ®Google Scholar
• Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, .; HPV Study Group. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002;87:324–33.
   PubMed Web of Science ®Google Scholar
• Matos E, Loria D, Amestoy GM, Herrera L, Prince MA, Moreno J, .; Proyecto Concordia Collaborative Group. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis 2003;30:593–9.
   PubMed Web of Science ®Google Scholar
• Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJ, Meijer CJ, . Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 2004; 13:2271–6.
   PubMed Web of Science ®Google Scholar
• Baay MF, Kjetland EF, Ndhlovu PD, Deschoolmeester V, Mduluza T, Gomo E, . Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution. J Med Virol 2004;73:481–5.
   PubMed Web of Science ®Google Scholar
• Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, . Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004;90:638–45.
   PubMed Web of Science ®Google Scholar
• Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, . Prevalence of HPV infection among females in the United States. JAMA 2007;297: 813–9.
   PubMed Web of Science ®Google Scholar
• Didelot-Rousseau MN, Courgnaud V, Nagot N, Ouedraogo A, Konate I, Mayaud P, . Comparison of INNO-LiPA HPV Genotyping v2 with PCR product subcloning and sequencing for identification of genital human papillomavirus genotypes in African women. J Virol Methods 2006; 135:181–5.
   PubMedGoogle Scholar
• Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, Shafer RW. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res 2007;17:1195–201.
   PubMed Web of Science ®Google Scholar
• Gharizadeh B, Ghaderi M, Donnelly D, Amini B, Wallin KL, Nyrén P. Multiple-primer DNA sequencing method. Electrophoresis 2003;24:1145–51.
   PubMed Web of Science ®Google Scholar